Tuesday, 18 June 2019

Drug Discovery News

  • FDA approves Amicus' Galafold for Fabry disease

    Drug Discovery |  News | 0 Comment | 13 Aug, 2018

    Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more

  • Pfizer's Innovative drug IBRANCE gets China approval

    Drug Discovery |  News | 0 Comment | 08 Aug, 2018

    Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more

  • DotBio successfully raises $2.3 M in seed financing

    Drug Discovery |  News | 0 Comment | 07 Aug, 2018

    Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully rai...Read more

  • Medpacto inks deal with AstraZeneca

    Drug Discovery |  News | 0 Comment | 02 Aug, 2018

    MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto’s vactosertib (TEW-7197), a small molecule, oral inhibitor of ...Read more

  • Pfizer's Herceptin biosimilar approved in Europe

    Drug Discovery |  News | 0 Comment | 31 Jul, 2018

    Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cancer med Herceptin (trastuzumab). TRAZIMERA, a potential biosimilar to ...Read more

  • Nektar's back pain opioid gets approval for FDA review

    Drug Discovery |  News | 0 Comment | 30 Jul, 2018

     Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more

  • Agios receives nod for ivosidenib

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more

  • FDA approves Pfizer's biosimilar

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected to hit the market at a significant discount to its reference drug. Th...Read more

  • FDA approves first drug indicating treatment of smallpox

    Drug Discovery |  News | 0 Comment | 16 Jul, 2018

     Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox. Though the World Health Or...Read more

  • Immatics, Genmab to develop bispecific cancer immunotherapies

    Drug Discovery |  News | 0 Comment | 12 Jul, 2018

    Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, has entered into a research c...Read more

  • FDA grants 7-year orphan drug exclusivity to Eagle

    Drug Discovery |  News | 0 Comment | 09 Jul, 2018

    Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seven years of orphan drug exclusivity (ODE) in the U.S., for BENDEKA (be...Read more

  • FDA grants ODD to OBI Pharma's lead investigational drug candidate

    Drug Discovery |  News | 0 Comment | 09 Jul, 2018

    OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for OBI-3424 for the Treatment of ...Read more

  • Biogen’s Alzheimer’s drug succeeds in trial

    Drug Discovery |  News | 0 Comment | 06 Jul, 2018

    Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an anti-amyloid beta protofibril antibody, in 856 patients with early A...Read more

  • Roche announces positive results of lung cancer drug Tecentriq

    Drug Discovery |  News | 0 Comment | 04 Jul, 2018

    Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) plus chemotherapy (Celgene’s Abraxane [albumin-bound paclitaxel;...Read more

  • Singapore institutes collaborate with ROK to develop innovative drugs

    Drug Discovery |  News | 0 Comment | 03 Jul, 2018

    Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research Laboratories, a leading research institute from the Republic of Korea...Read more

  • Lumicks teams up with AZ, UC to set up CoE

    Drug Discovery |  News | 0 Comment | 28 Jun, 2018

    LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambridge Biochemistry Department to form the 'centre of Excellence for Dyn...Read more

  • Ascletis, CR Pharma sign strategic cooperation agreement

    Drug Discovery |  News | 0 Comment | 27 Jun, 2018

    Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parties signed a strategic cooperation agreement in Beijing. The two parti...Read more

  • AUM Biosciences to drive commercial innovation in oncology

    Drug Discovery |  News | 0 Comment | 25 Jun, 2018

    Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology medicines with high unmet medical need in Asia, officially launched to...Read more



Survey Box

Is Asia becoming the centre of healthcare transformation?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls